ArticleNeurology(R) neuroimmunology & neuroinflammation2023

International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab.

Friedemann Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.